|
| Exchange Disseminated Time 23/01/2017 10:14:06 | Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on February 04, 2017, inter alia, to consider and approve, the un-audited financial results for the quarter and nine months ended December 31, 2016(Q3).
Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from January 28, 2017 to February 06, 2017 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. |
|
|